Edwards Lifesciences
Edwards Lifesciences is American medical technology company. Founded in 1956. Approximately 14,000 employees. (Wikidata)
Edwards Lifesciences's strongest tracked position is the Interventional Cardiology Market at an estimated 10.0% share in a market growing at 6.3% CAGR.
Meridian Consensus tracks Edwards Lifesciences in 1 market across 1 industry (Healthcare). Estimated in-market revenue is $1.9B, the sum of share × market size across appearances — a modeled figure, not reported company revenue.
Filed financials · SEC 10-K · FY2025
EDGAR · CIK 1099800Exchange-filed figures from SEC XBRL companyfacts (Edwards Lifesciences Corp). The modeled in-market estimates below cover only the markets Meridian tracks and will not sum to filed revenue.
Share and revenue figures are Meridian model estimates reconciled through the publish-gate validator, not audited financials. Methodology
Market positions
| Market | CAGR | Share |
|---|---|---|
| Interventional Cardiology Market | 6.3% | 10.0% |
Meridian Dossier
Need diligence-grade depth on Edwards Lifesciences?
Commission a source-cited diligence dossier on Edwards Lifesciences: identity, filed financials, IP, litigation, and government exposure. Free preview first, from $299.
Edwards Lifesciences: frequently asked
Meridian Consensus tracks Edwards Lifesciences in 1 market: Interventional Cardiology Market ($18.5B), spanning Healthcare.
Edwards Lifesciences's strongest tracked position is the Interventional Cardiology Market, a $18.5B market growing at 6.3% CAGR, where it holds an estimated 10.0% share as of May 2026.
Across Meridian-tracked markets, Edwards Lifesciences's closest peers are Abbott Laboratories, Boston Scientific, Medtronic plc, Terumo Corporation, B. Braun Melsungen, with the largest overlap in the Interventional Cardiology Market. Peer mapping is based on co-appearance in the same tracked markets.
No. Share and revenue figures on this page are model estimates produced by Meridian's research pipeline and committee-reviewed before publication; they are not audited or exchange-filed financials. Market-level sizings are reconciled against external sources during the publish gate.
Adjacent markets in Healthcare
Tracked markets in the same industry where Edwards Lifesciences is not among the named operators. Each carries Porter Five Forces, SWOT, country analysis, and a full competitor table.
Operators that compete with Edwards Lifesciences
Edwards Lifesciences's closest peers across Meridian-tracked markets are Abbott Laboratories, Boston Scientific, Medtronic plc, among others, ordered by how many tracked markets they share with the operator.
- 1 sharedAbbott LaboratoriesTop overlap · Interventional Cardiology
- 1 sharedBoston ScientificTop overlap · Interventional Cardiology
- 1 sharedMedtronic plcTop overlap · Interventional Cardiology
- 1 sharedTerumo CorporationTop overlap · Interventional Cardiology
- 1 sharedB. Braun MelsungenTop overlap · Interventional Cardiology
- 1 sharedCook MedicalTop overlap · Interventional Cardiology
- 1 sharedTeleflexTop overlap · Interventional Cardiology
- 1 sharedCardinal HealthTop overlap · Interventional Cardiology
- 1 sharedMicroPort ScientificTop overlap · Interventional Cardiology
- 1 sharedBiotronikTop overlap · Interventional Cardiology
Or browse the full A–Z operator directory for any company in the catalogue.
Meridian Consensus Digest
Free · WeeklyNot ready to commission a full report? Get our weekly briefing instead: new market sizings, thesis revisions, and reconciliation updates. Signed by the research team. No sales emails.